Literature DB >> 2545913

Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities.

S A Rice1, L S Su, D M Knipe.   

Abstract

The HSV-1 alpha (immediate-early) protein ICP27 expressed in transfected cells can activate the expression of certain HSV-1 promoters as well as inhibit the transactivated expression of others. We constructed a set of plasmids encoding mutant ICP27 molecules truncated at their carboxyl termini and used transfection assays to determine the functional properties of the mutant proteins. A polypeptide containing the amino-terminal 263 amino acid residues of ICP27 retained partial ability to activate gene expression but was unable to inhibit transactivation. Mutant proteins possessing 406 or 504 amino acids of ICP27 were unable to activate gene expression but retained full ability to inhibit transactivation. These results define two separable regulatory activities of ICP27, one positive and one negative, which can modulate gene expression in transfected cells. Immunoblot and immunofluorescence experiments were used to study the immunological reactivities and intracellular localizations of the mutant proteins. All proteins possessing the amino-terminal 263 amino acids of ICP27 reacted with an ICP27-specific monoclonal antibody and were localized to the cell nucleus. The mutant proteins, however, exhibited a number of phenotypes with regard to intranuclear localization. A mutant possessing 504 residues of ICP27 was similar to the wild-type protein in apparently localizing to all regions of the nucleus. A mutant containing 406 residues of ICP27, on the other hand, was mostly excluded from the nucleolar regions, while a 263-residue mutant was localized predominantly in the nucleoli. Thus, some aspect of ICP27 structure or function can dramatically affect its intranuclear distribution.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545913      PMCID: PMC250915          DOI: 10.1128/JVI.63.8.3399-3407.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A genetic test for expression of a functional herpes simplex virus DNA-binding protein from a transfected plasmid.

Authors:  M P Quinlan; D M Knipe
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

2.  Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro.

Authors:  K A Jones; K R Yamamoto; R Tjian
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

3.  Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein.

Authors:  P M Lieberman; P O'Hare; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus.

Authors:  D M Knipe; A E Spang
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

5.  Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.

Authors:  K M Wong; A J Levine
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.

Authors:  M Ackermann; D K Braun; L Pereira; B Roizman
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro.

Authors:  K A Jones; R Tjian
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

9.  Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5).

Authors:  R H Costa; K G Draper; G Devi-Rao; R L Thompson; E K Wagner
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Cloning of herpes simplex virus type 1 sequences representing the whole genome.

Authors:  A L Goldin; R M Sandri-Goldin; M Levine; J C Glorioso
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

View more
  50 in total

1.  Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.

Authors:  T M Soliman; S J Silverstein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Processing of alpha-globin and ICP0 mRNA in cells infected with herpes simplex virus type 1 ICP27 mutants.

Authors:  K S Ellison; S A Rice; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 4.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

5.  Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27.

Authors:  Kimberly S Ellison; Robert A Maranchuk; Kelly L Mottet; James R Smiley
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Equimolar generation of the four possible arrangements of adjacent L components in herpes simplex virus type 1 replicative intermediates.

Authors:  D Bataille; A L Epstein
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Mutations in the activation region of herpes simplex virus regulatory protein ICP27 can be trans dominant.

Authors:  I L Smith; R E Sekulovich; M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

9.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Authors:  M Winkler; S A Rice; T Stamminger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.